[1例肝细胞癌合并骨转移经多学科治疗成功]。

Q4 Medicine
Toshihiko Goto, Susumu Sawada, Kunpei Ishida, Rina Ko, Yuta Iwasaki, Nozomu Nakanishi, Koshiro Morino, Norihiro Shimoike, Hirokazu Tanaka, Ryo Matsusue, Michihiro Yamamoto, Takafumi Machimoto
{"title":"[1例肝细胞癌合并骨转移经多学科治疗成功]。","authors":"Toshihiko Goto, Susumu Sawada, Kunpei Ishida, Rina Ko, Yuta Iwasaki, Nozomu Nakanishi, Koshiro Morino, Norihiro Shimoike, Hirokazu Tanaka, Ryo Matsusue, Michihiro Yamamoto, Takafumi Machimoto","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The patient was a 52-year-old male, who, after experiencing lower back pain, underwent further investigation and was diagnosed with hepatocellular carcinoma with sacral metastasis. The hepatocellular carcinoma was a 9 cm tumor with a risk of rupture. Liver resection was performed, and lenvatinib was initiated at a dose of 4 mg/day postoperatively. Radical radiation therapy was then administered to address bone metastases. Lenvatinib was discontinued after 15 months due to skin disorders. Seven months have passed since the discontinuation of lenvatinib and 2 years since surgery. The patient's condition has progressed without any recurrence.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 12","pages":"1243-1245"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[A Case of Hepatocellular Carcinoma with Simultaneous Bone Metastasis Successfully Treated with Multidisciplinary Therapy].\",\"authors\":\"Toshihiko Goto, Susumu Sawada, Kunpei Ishida, Rina Ko, Yuta Iwasaki, Nozomu Nakanishi, Koshiro Morino, Norihiro Shimoike, Hirokazu Tanaka, Ryo Matsusue, Michihiro Yamamoto, Takafumi Machimoto\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The patient was a 52-year-old male, who, after experiencing lower back pain, underwent further investigation and was diagnosed with hepatocellular carcinoma with sacral metastasis. The hepatocellular carcinoma was a 9 cm tumor with a risk of rupture. Liver resection was performed, and lenvatinib was initiated at a dose of 4 mg/day postoperatively. Radical radiation therapy was then administered to address bone metastases. Lenvatinib was discontinued after 15 months due to skin disorders. Seven months have passed since the discontinuation of lenvatinib and 2 years since surgery. The patient's condition has progressed without any recurrence.</p>\",\"PeriodicalId\":35588,\"journal\":{\"name\":\"Japanese Journal of Cancer and Chemotherapy\",\"volume\":\"51 12\",\"pages\":\"1243-1245\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Cancer and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

患者是一名52岁的男性,在经历了腰痛后,接受了进一步的检查,并被诊断为肝细胞癌伴骶骨转移。肝细胞癌是一个9厘米的肿瘤,有破裂的危险。进行肝切除术,术后开始使用lenvatinib,剂量为4mg /天。然后给予根治性放射治疗以解决骨转移。Lenvatinib因皮肤疾病在15个月后停用。lenvatinib停药7个月,手术2年。病人的病情有进展,没有复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[A Case of Hepatocellular Carcinoma with Simultaneous Bone Metastasis Successfully Treated with Multidisciplinary Therapy].

The patient was a 52-year-old male, who, after experiencing lower back pain, underwent further investigation and was diagnosed with hepatocellular carcinoma with sacral metastasis. The hepatocellular carcinoma was a 9 cm tumor with a risk of rupture. Liver resection was performed, and lenvatinib was initiated at a dose of 4 mg/day postoperatively. Radical radiation therapy was then administered to address bone metastases. Lenvatinib was discontinued after 15 months due to skin disorders. Seven months have passed since the discontinuation of lenvatinib and 2 years since surgery. The patient's condition has progressed without any recurrence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信